Kobo Biotech Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	-52.3	-49.29	-55.53	-152.26	-192.31
Depreciation & Amortization	40.71	40.71	40.72	46.06	56.37
Other Operating Activities	0	-	-	1.34	108.41
Change in Accounts Receivable	-0.5	-0.13	-1.56	806.75	8.14
Change in Inventory	-	-	-	352.38	-
Change in Accounts Payable	11.23	10.45	25.63	-82.79	33.72
Change in Other Net Operating Assets	42.6	0.29	-0.51	-33.92	10.77
Operating Cash Flow	41.75	2.04	8.75	937.57	25.09
Operating Cash Flow Growth	1950.69%	-76.72%	-99.07%	3636.53%	-82.67%
Sale of Property, Plant & Equipment	-	-	-	128.92	-
Investment in Securities	-	-	-	121.93	-
Other Investing Activities	-	-	-	0.05	-
Investing Cash Flow	-	-	-	250.9	-
Short-Term Debt Issued	-	7.96	-	-	111.62
Total Debt Issued	-	7.96	-	-	111.62
Short-Term Debt Repaid	-	-	-	-1,198	-
Long-Term Debt Repaid	-	-9.46	-8.74	-3.31	-13.99
Total Debt Repaid	-	-9.46	-8.74	-1,201	-13.99
Net Debt Issued (Repaid)	-	-1.5	-8.74	-1,201	97.63
Other Financing Activities	-	-	-	-1.34	-108.41
Financing Cash Flow	-	-1.5	-8.74	-1,203	-10.77
Net Cash Flow	41.75	0.54	0.01	-14.34	14.32
Free Cash Flow	41.75	2.04	8.75	937.57	25.09
Free Cash Flow Growth	1950.69%	-76.72%	-99.07%	3636.53%	-82.66%
Free Cash Flow Per Share	1.75	0.09	0.37	39.35	1.05
Cash Interest Paid	-	-	-	1.34	108.41
Levered Free Cash Flow	61.98	20.71	32.92	975.9	-7.52
Unlevered Free Cash Flow	61.98	20.71	32.92	976.74	59.98
Change in Working Capital	53.34	10.61	23.56	1,042	52.63